Washington University in St. Louis (WU)
Glomerular diseases are a well-recognized cause of chronic kidney disease and end-stage renal disease. These disorders are frequently associated with significant morbidity and mortality due not only to organ damage from the disease process itself, but also toxicities of therapeutic agents, in addition to the much increased risk of cardiovascular mortality. My research is focused on the development of safer and more effective therapies for glomerular diseases while exploring the underlying disease mechanisms, with the goals of improving disease remission rates, long-term kidney outcomes, as well as overall patient outcomes.